The assessment of breathlessness in pulmonary arterial hypertension: Reliability and validity of the Dyspnoea-12

European Journal of Cardiovascular Nursing

Volumn 13, Issue 6, 2014, Pages 506-514

  Yorke, Janelle ^a   Armstrong, Iain ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

breathlessness; dyspnoea; instrument design; patient assessment; patient reported outcome measure; psychometrics; Pulmonary arterial hypertension

Indexed keywords

6 MINUTE WALK DISTANCE TEST; ADULT; ANXIETY; ARTICLE; CONGENITAL HEART DISEASE; CONNECTIVE TISSUE DISEASE; DEPRESSION; DISEASE SEVERITY; DYSPNEA; DYSPNEA 12; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HEART FAILURE PULMONARY HYPERTENSION MODIFIED VERSION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PSYCHOMETRY; PULMONARY HYPERTENSION; RELIABILITY; SCORING SYSTEM; TEST RETEST RELIABILITY; VALIDITY; WORLD HEALTH ORGANIZATION FUNCTIONAL CLASS; AGE; AGED; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HYPERTENSION, PULMONARY; MIDDLE AGED; OUTCOME ASSESSMENT; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; RISK ASSESSMENT; SEX DIFFERENCE; VALIDATION STUDY;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DYSPNEA; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEX FACTORS;

EID: 84897423362     PISSN: 14745151     EISSN: 18731953     Source Type: Journal    
DOI: 10.1177/1474515113514891     Document Type: Article

References (36)

1. Kiely DG, Elliot CA, Sabroe I, et al. Pulmonary hypertension: Diagnosis and management. BMJ. 2013 ; 346: f2028
2. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009 ; 30: 2493-2537
3. Armstrong I, Harries C, Rochnia N, et al. The trajectory to diagnosis with pulmonary hypertension: A qualitative study. BMJ Open. 2012 ; 18 :
4. McDonough A, Matura LA, Carroll DL. Symptom experience of pulmonary arterial hypertension patients. Clin Nurs Res. 2011 ; 20: 120-134
5. Flattery MP, Pinson JM, Savage L, et al. Living with pulmonary arterial hypertension: Patient's experiences. Heart Lung. 2005 ; 34: 99-107
6. Shafazand S, Goldstein MK, Doyle RL, et al. Health-related quality of life in patients with pulmonary hypertension. Chest. 2004 ; 126: 1452-1459
7. Taichman DB, Shin J, Hud J, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res. 2005 ; 6: 92
8. Cenedese E, Speich R, Dorschner S, et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Resp J. 2006 ; 28: 808-815
9. Mantura LA, McDonough A, Carroll DL. Cluster analysis of symptoms in pulmonary arterial hypertension: A pilot study. Eur J Cardiovasc Nurs. 2012 ; 11: 51-61
10. Banzett RB, Moosavi S. Dyspnea and pain: Similarities and contrasts between two very unpleasant sensations. APS Bulletin. 2001 ; 11: 1-8
11. Parshal MB, Schwartzstein RM, Adams L, et al. An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea. Am J Respir Crit Care Med. 2012 ; 185: 435-452
12. Braido F, Baiardini I, Menoni S, et al. Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opi. 2011 ; 27: 981-986
13. Edmonds P, Karlsen S, Khan S, et al. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001 ; 15: 287-295
14. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982 ; 14: 377
15. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of Dyspnoea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984 ; 85: 751-758
16. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 ; 142: 773-778
17. Mahler DA, Selecky PA, Harrod CG, et al. American College of chest physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest. 2010 ; 137: 674-691
18. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of breathlessness using descriptors: Development and initial testing of Dyspnoea-12. Thorax. 2010 ; 65: 21-26
19. Yorke J, Swigirs J, Russell AM, et al. Dyspnoea-12 is a valid and reliable measure of breathlessness in patients with ILD. Chest. 2011 ; 139: 159-164
20. Swigris J, Yorke J, Sprunger D, et al. The impact of dyspnoea on patients with connective tissue disease-related ILD. Respir Med. 2010 ; 104: 1350-1355
21. Yorke J, Russell A, Swigris J, et al. Assessment of dyspnoea in asthma: Validation of the Dyspnoea-12. J Asthma. 2011 ; 48: 602-608
22. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 ; 126: 14S - 34S
23. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 ; 166: 111-117
24. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure. Part 2: Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure. 1987 ;: 198-209
25. Zlupko M, Harhay MO, Gallop R, et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med. 2008 ; 102: 1431-1438
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psych Scand. 1983 ; 67: 361-370
27. Crawford JR, Henry JD, Crombie C, et al. Normative data for the HADS from a large non-clinical sample. Br J Clin Psych. 2001 ; 40: 429-434
28. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951 ; 16: 297-334
29. Coolican H Research methods and statistics in psychology. 5 th ed. London: Hodder Education, 2009, p.194. London: Hodder Education ; 2009: 194.
30. McCollister DH, Beutz M, McLaughlin V, et al. Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional class. Psychosomatics. 2010 ; 41 (4). 339-339.e8
31. Badesch DB, Raskob GE, Elliot CG, et al. Pulmonary arterial hypertension: Baseline characteristics from the REVEAL Registry. Chest. 2012 ; 137: 376-387
32. Chen H, Taichman DB, Doyle RL. Health-related quality of life and patient-reported outcomes in pulmonary Arterial hypertension. Proc Am Thorac Soc. 2008 ; 5: 623-630
33. Lowe B, Grafe K, Ufer C, et al. Anxiety and depression in patients with pulmonary hypertension. Psychosom Med. 2004 ; 66: 831-836
34. Abernethy AP, McDonal CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: A double-blind, randomised controlled trial. Lancet. 2010 ; 376: 784-793
35. Barst RJ, Gibbs JS, Ghofrani HA, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009 ; 54: S78
36. McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. The Cambridge pulmonary hypertension outcome review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006 ; 15: 103-115